Clinical Trial: Determination of the Optimal Volume of 0.5% Bupivacaine Liposome in Single-Injection Interscalene Brachial Plexus Block: A Bayesian Phase I/II Trial

U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT06972680) titled 'Determination of the Optimal Volume of 0.5% Bupivacaine Liposome in Single-Injection Interscalene Brachial Plexus Block: A Bayesian Phase I/II Trial' on April 07.

Brief Summary: This single-center, prospective, single-arm, Bayesian phase I/II clinical trial evaluates the incidence of HDP following ISB in shoulder arthroscopy and determines the optimal volume of a single injection of liposomal bupivacaine.

Study Start Date: May 01

Study Type: OBSERVATIONAL

Condition: Shoulder Arthroscopy

Intervention: DRUG: Bupivacaine Liposomes(BL)

Prior to surgery, an interscalene brachial plexus block was performed, injecting the preset volu...